Pluri Inc. Shareholders' Equity
Pluri Inc. (PLUR) had Shareholders' Equity of -$23.04 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-10
- 2026-06-30: Stockholders' Equity Attributable to Parent -$23.04M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$18.60M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$14.61M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$11.36M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$23.04M 10-K · filed 2026-09-10 | |
| 2026-03-31 | -$18.60M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$14.61M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | -$11.36M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$6.84M 10-K · filed 2026-09-10 | |
| 2025-03-31 | -$4.47M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$8.03M 10-Q · filed 2025-02-11 | |
| 2024-09-30 | -$5.28M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $96.00K 10-K · filed 2025-09-17 | |
| 2024-03-31 | -$356.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $4.40M 10-Q · filed 2024-02-12 | |
| 2023-09-30 | $8.90M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $13.36M 10-K · filed 2024-09-18 | |
| 2023-03-31 | $19.06M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $23.19M 10-Q · filed 2023-02-13 | |
| 2022-09-30 | $24.19M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $30.04M 10-K · filed 2023-09-12 | |
| 2022-03-31 | $38.09M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $39.84M 10-Q · filed 2022-02-07 | |
| 2021-09-30 | $48.91M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $57.15M 10-K · filed 2022-09-21 | |
| 2021-03-31 | $68.14M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $41.15M 10-Q · filed 2021-05-06 | |
| 2020-09-30 | $48.95M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $56.10M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $14.17M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $15.91M 10-Q · filed 2021-05-06 | |
| 2019-09-30 | $17.53M 10-Q · filed 2021-02-08 | |
| 2019-06-30 | $21.82M 10-K · filed 2021-09-13 | |
| 2019-03-31 | $8.63M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $15.19M 10-Q · filed 2020-05-11 | |
| 2018-09-30 | $21.53M 10-Q · filed 2020-02-06 | |
| 2018-06-30 | $28.51M 10-K · filed 2020-09-10 | |
| 2018-03-31 | $33.23M 10-Q · filed 2019-05-06 | |
| 2017-12-31 | $36.96M 10-Q · filed 2019-05-06 | |
| 2017-09-30 | $24.36M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $30.25M 10-K · filed 2020-09-10 | |
| 2017-03-31 | $35.62M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $25.11M 10-Q · filed 2018-02-06 | |
| 2016-09-30 | $32.90M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $38.16M 10-K · filed 2019-09-12 | |
| 2016-03-31 | $43.11M 10-Q · filed 2017-05-08 | |
| 2015-12-31 | $49.35M 10-Q · filed 2017-02-08 | |
| 2015-09-30 | $52.35M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $58.14M 10-K · filed 2018-09-12 | |
| 2015-03-31 | $45.55M 10-Q · filed 2016-05-09 | |
| 2014-12-31 | $49.14M 10-Q · filed 2016-02-08 | |
| 2014-09-30 | $53.70M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $62.12M 10-K · filed 2017-09-07 | |
| 2014-03-31 | $65.96M 10-Q · filed 2015-05-06 | |
| 2013-12-31 | $60.83M 10-Q · filed 2015-02-05 | |
| 2013-09-30 | $54.79M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $57.47M 10-K · filed 2016-09-07 | |
| 2013-03-31 | $64.02M 10-Q · filed 2014-05-08 | |
| 2012-12-31 | $69.04M 10-Q · filed 2014-02-05 | $69.04K 10-Q · filed 2013-01-31 |
| 2012-09-30 | $72.19M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $37.74M 10-K · filed 2015-09-09 | |
| 2012-03-31 | $37.90M 10-Q · filed 2013-05-08 | |
| 2011-12-31 | $40.35K 10-Q · filed 2013-01-31 | $40.35M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $40.29M 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $43.42M 10-K · filed 2014-09-11 | |
| 2011-03-31 | $45.74M 10-Q · filed 2012-05-08 | |
| 2010-06-30 | $3.98M 10-K · filed 2013-09-11 | |
| 2009-06-30 | $3.39M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |